Relevant bibliographies by topics / Diabetes – Prevention / Journal articles

Journal articles on the topic 'Diabetes – Prevention'

To see the other types of publications on this topic, follow the link: Diabetes – Prevention.
Author: Grafiati
Published: 4 June 2021
Last updated: 7 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Diabetes – Prevention.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Barclay, Chris, and Nigel Mathers. "Diabetes prevention." British Journal of General Practice 58, no. 557 (December 1, 2008): 887.2–887. http://dx.doi.org/10.3399/bjgp08x376249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Davis-Lameloise, Nathalie, Benjamin Philpot, Prasuna Reddy, and James A. Dunbar. "Diabetes prevention." British Journal of General Practice 58, no. 557 (December 1, 2008): 887.3–888. http://dx.doi.org/10.3399/bjgp08x376258.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kelly, Sarah Dion. "Diabetes Prevention." Physician Assistant Clinics 7, no. 1 (January 2022): 1–12. http://dx.doi.org/10.1016/j.cpha.2021.08.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Piper, Sarah. "Diabetes Prevention." AADE in Practice 1, no. 1 (January 2013): 10–13. http://dx.doi.org/10.1177/2325160312471799.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Moses, Alan C., Michael Mawby, and Anne M. Phillips. "Diabetes Prevention." American Journal of Preventive Medicine 44, no. 4 (April 2013): S333—S338. http://dx.doi.org/10.1016/j.amepre.2012.12.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Brooks, John L. "Diabetes Prevention." American Journal of Preventive Medicine 44, no. 4 (April 2013): S299—S300. http://dx.doi.org/10.1016/j.amepre.2013.01.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sodikovna, Abdurazakova Dilbar, Yusupova Shahnoza Kadirjanovna, SaidjonovaFeruza Latifjonovna, and Jabbarov Ibrohimjon Adhamjon O’gli. "PREVENTION OF TYPE 2 DIABETES MELLITUS." American Journal Of Biomedical Science & Pharmaceutical Innovation 4, no. 3 (March 1, 2024): 44–51. http://dx.doi.org/10.37547/ajbspi/volume04issue03-06.

Full text
Abstract:
Prevention of type 2 diabetes mellitus and complications is an urgent problem in modern medicine. In patients with a body mass index (BMI) above 25 kg/m2, indicators of markers of carbohydrate metabolism (serum glucose -fasting and postprandial glycemia, glycosylated hemoglobin and urine glucose) and lipid metabolism -total cholesterol (TC), triglycerides (TG), lipidogram (low-density lipoprotein cholesterol -LDL cholesterol, atherogenic index -AI is significantly higher, and high-density lipoprotein cholesterol -HDL cholesterol is significantly lower than in patients with normal body mass index (BMI) and abdominal index (AI). Asignificant positive relationship between age, abdominal index, BMI, AI, glucose level in blood serum. Assessment of markers of carbohydrate and lipid metabolism should be included in the list of mandatory examinations of patients over the age of 30 years, and be strictly individual. There is a relationship between the progression of carbohydrate metabolism disorders and changes in lipid parameters metabolism in the examined women.The population should be widely informed about the development of type 2 diabetes mellitus and the progression of complications.
APA, Harvard, Vancouver, ISO, and other styles
8

Aroda, Vanita R., William C. Knowler, Jill P. Crandall, Leigh Perreault, Sharon L. Edelstein, Susan L. Jeffries, Mark E. Molitch, et al. "Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study." Diabetologia 60, no. 9 (August 2, 2017): 1601–11. http://dx.doi.org/10.1007/s00125-017-4361-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Azizur Rahman, Mohammad, and Rabeya Akter. "Diabetes Ameliorating Effect of Mushrooms and ameliorating diabetes." Diabetes and Islet Biology 5, no. 1 (January 11, 2022): 01–05. http://dx.doi.org/10.31579/2641-8975/026.

Full text
Abstract:
The growing impact of type 2 diabetes in the majority of the population requires the introduction of better and more secure treatments, but also requires the development of new prevention strategies to reduce the incidence and prevalence of the disease. Significantly, type 2 diabetes is an important preventable disease and can be prevented or delayed by lifestyle intervention. Edible and medicinal macrofungi, mushrooms have been reported having diabetes ameliorating effects. Current study reviews the potentiality of both edible and medicinal mushrooms in preventing and ameliorating the diabetic complications as well as the future aspects of mushrooms against this metabolic disorder.
APA, Harvard, Vancouver, ISO, and other styles
10

&NA;. "Diabetes Prevention Trial." Endocrinologist 6, no. 5 (September 1996): 417. http://dx.doi.org/10.1097/00019616-199609000-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Allende-Vigo, Myriam Zaydee. "Diabetes Mellitus Prevention." American Journal of Therapeutics 22, no. 1 (2015): 68–72. http://dx.doi.org/10.1097/mjt.0b013e3182211bae.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Ramachandran, A., and C. Snehalatha. "Diabetes Prevention Programs." Medical Clinics of North America 95, no. 2 (March 2011): 353–72. http://dx.doi.org/10.1016/j.mcna.2010.11.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Vinicor, Frank, Barbara Bowman, and Michael Engelgau. "Diabetes: prevention needed." Lancet 361, no. 9357 (February 2003): 544. http://dx.doi.org/10.1016/s0140-6736(03)12561-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

EBBERT, JON O., and ERIC G. TANGALOS. "Diabetes Prevention Strategies." Internal Medicine News 39, no. 4 (February 2006): 30. http://dx.doi.org/10.1016/s1097-8690(06)72877-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Utz, Sharon Williams. "Diabetes Prevention Materials." Family & Community Health 28, no. 1 (January 2005): 98–100. http://dx.doi.org/10.1097/00003727-200501000-00017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Heneghan, Carl, M. Thompson, and R. Perera. "Prevention of diabetes." BMJ 333, no. 7572 (October 12, 2006): 764–65. http://dx.doi.org/10.1136/bmj.38996.709340.be.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Laws, Rachel A., Alexis B. St.George, Lucie Rychetnik, and Adrian E. Bauman. "Diabetes Prevention Research." American Journal of Preventive Medicine 43, no. 2 (August 2012): 205–14. http://dx.doi.org/10.1016/j.amepre.2012.04.017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Makrilakis, Konstantinos, and Nikolaos Katsilambros. "Prediction and prevention of type 2 diabetes." HORMONES 2, no. 1 (January 15, 2003): 22–34. http://dx.doi.org/10.14310/horm.2002.1179.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Laaksonen, D. E., J. Lindstrom, T. A. Lakka, J. G. Eriksson, L. Niskanen, K. Wikstrom, S. Aunola, et al. "Physical Activity in the Prevention of Type 2 Diabetes: The Finnish Diabetes Prevention Study." Diabetes 54, no. 1 (December 22, 2004): 158–65. http://dx.doi.org/10.2337/diabetes.54.1.158.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Hansen, B. C., and N. L. Bodkin. "Primary prevention of diabetes mellitus by prevention of obesity in monkeys." Diabetes 42, no. 12 (December 1, 1993): 1809–14. http://dx.doi.org/10.2337/diabetes.42.12.1809.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Lin, James, Horng-Yih Ou, Lee-Ming Chuang, and Ken C. Chiu. "Diabetes prevention through prevention of hepatitis B." Hepatology 64, no. 3 (February 19, 2016): 987–88. http://dx.doi.org/10.1002/hep.28399.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Bajpai, Ritika. "Challenges and Strategies for Prevention Understanding Diabetes Mellitus." International Journal of Science and Research (IJSR) 12, no. 9 (September 5, 2023): 1523–24. http://dx.doi.org/10.21275/sr23913144759.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Wymer, Joshua A. "National Diabetes Prevention Program." Health Affairs 41, no. 4 (April 1, 2022): 608. http://dx.doi.org/10.1377/hlthaff.2021.01961.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Young, Jang Mi. "Diet for Diabetes Prevention." Korean Clinical Diabetes 9, no. 2 (2008): 123. http://dx.doi.org/10.4093/kcd.2008.9.2.123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Piper, Sarah, Carissa Beatty, Linelle Blais, Natalie D. Ritchie, and Rocio I. Pereira. "Pathways to Diabetes Prevention." AADE in Practice 4, no. 6 (October 25, 2016): 32–36. http://dx.doi.org/10.1177/2325160316668158.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Adler, A. I., and R. C. Turner. "The diabetes prevention program." Diabetes Care 22, no. 4 (April 1, 1999): 543–45. http://dx.doi.org/10.2337/diacare.22.4.543.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Ramiya, V. K., and N. K. Maclaren. "Insulin in Diabetes Prevention." Hormone Research 48, no. 4 (1997): 67–70. http://dx.doi.org/10.1159/000191318.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

YU, LIPING, DAVID D. CUTHBERTSON, GEORGE S. EISENBARTH, and JEFFREY P. KRISCHER. "Diabetes Prevention Trial 1." Annals of the New York Academy of Sciences 958, no. 1 (January 24, 2006): 254–58. http://dx.doi.org/10.1111/j.1749-6632.2002.tb02981.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Behme, Margaret T. "Nicotinamide and Diabetes Prevention." Nutrition Reviews 53, no. 5 (April 27, 2009): 137–39. http://dx.doi.org/10.1111/j.1753-4887.1995.tb01538.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Fain, James A. "AADE’s Diabetes Prevention Program." Diabetes Educator 42, no. 6 (November 9, 2016): 665. http://dx.doi.org/10.1177/0145721716677215.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Colwell, John A. "Prevention of diabetes complications." Clinical Cornerstone 1, no. 3 (January 1998): 58–71. http://dx.doi.org/10.1016/s1098-3597(98)90018-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Yudkin, John S., and Christopher Millett. "Diabetes prevention in England." Lancet Diabetes & Endocrinology 3, no. 7 (July 2015): 502. http://dx.doi.org/10.1016/s2213-8587(15)00211-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Muniyappa, Ranganath, Fadi El-Atat, Ashish Aneja, and Samy I. McFarlane. "The diabetes prevention program." Current Diabetes Reports 3, no. 3 (May 2003): 221–22. http://dx.doi.org/10.1007/s11892-003-0067-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Hitman, G. A. "Type 2 diabetes prevention." Diabetic Medicine 30, no. 1 (December 13, 2012): 1. http://dx.doi.org/10.1111/dme.12064.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Herman, William H., and Wen Ye. "Precision Prevention of Diabetes." Diabetes Care 46, no. 11 (October 27, 2023): 1894–96. http://dx.doi.org/10.2337/dci23-0052.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Murray, Nikki J., Sara Abadi, Aliceon Blair, Melanie Dunk, and Mike J. Sampson. "The importance of type 2 diabetes prevention: The Norfolk Diabetes Prevention Study." British Journal of Diabetes & Vascular Disease 11, no. 6 (November 2011): 308–13. http://dx.doi.org/10.1177/1474651411429239.

Full text
Abstract:
Many large studies have investigated the prevention of type 2 diabetes in people at high risk of the condition, usually with changes in diet and physical activity levels. It is estimated that 2.25 million people in the UK have type 2 diabetes, with significant personal and healthcare costs, and the value of preventative measures in tackling this enormous public health challenge are well described. The Norfolk Diabetes Prevention Study (Norfolk DPS) will screen 10,000 people at risk of type 2 diabetes over five years, randomising 950 people with ‘pre-diabetes’ into a 36-month randomised controlled trial (three-armed study) of a novel diet and lifestyle intervention. The Norfolk DPS team is multidisciplinary and the intervention will be delivered by healthcare professionals in group settings. One arm will be part delivered by lay mentors who have existing type 2 diabetes. There is no UK-validated diet and lifestyle intervention for the prevention of type 2 diabetes in high risk groups that has been tested in a controlled trial, and an intervention delivered by those with existing type 2 diabetes has not been studied. The Norfolk DPS will provide further evidence in these areas.
APA, Harvard, Vancouver, ISO, and other styles
37

Kennedy, L. "Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program." Yearbook of Medicine 2006 (January 2006): 474–76. http://dx.doi.org/10.1016/s0084-3873(08)70600-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Kennedy, L. "Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program." Yearbook of Endocrinology 2006 (January 2006): 14–16. http://dx.doi.org/10.1016/s0084-3741(08)70264-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Lie, M. L. S., L. Hayes, N. J. Lewis-Barned, C. May, M. White, and R. Bell. "Preventing Type 2 diabetes after gestational diabetes: women's experiences and implications for diabetes prevention interventions." Diabetic Medicine 30, no. 8 (April 19, 2013): 986–93. http://dx.doi.org/10.1111/dme.12206.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Evert, A. B. "Gestational Diabetes Education and Diabetes Prevention Strategies." Diabetes Spectrum 19, no. 3 (July 1, 2006): 135–39. http://dx.doi.org/10.2337/diaspect.19.3.135.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Boltri, John M., Howard Tracer, David Strogatz, Shannon Idzik, Pat Schumacher, Naomi Fukagawa, Ellen Leake, et al. "The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes." Diabetes Care 46, no. 2 (January 26, 2023): e39-e50. http://dx.doi.org/10.2337/dc22-0620.

Full text
Abstract:
Individuals with an elevated fasting glucose level, elevated glucose level after glucose challenge, or elevated hemoglobin A1c level below the diagnostic threshold for diabetes (collectively termed prediabetes) are at increased risk for type 2 diabetes. More than one-third of U.S. adults have prediabetes but fewer than one in five are aware of the diagnosis. Rigorous scientific research has demonstrated the efficacy of both intensive lifestyle interventions and metformin in delaying or preventing progression from prediabetes to type 2 diabetes. The National Clinical Care Commission (NCCC) was a federal advisory committee charged with evaluating and making recommendations to improve federal programs related to the prevention of diabetes and its complications. In this article, we describe the recommendations of an NCCC subcommittee that focused primarily on prevention of type 2 diabetes in people with prediabetes. These recommendations aim to improve current federal diabetes prevention activities by 1) increasing awareness of and diagnosis of prediabetes on a population basis; 2) increasing the availability of, referral to, and insurance coverage for the National Diabetes Prevention Program and the Medicare Diabetes Prevention Program; 3) facilitating Food and Drug Administration review and approval of metformin for diabetes prevention; and 4) supporting research to enhance the effectiveness of diabetes prevention. Cognizant of the burden of type 1 diabetes, the recommendations also highlight the importance of research to advance our understanding of the etiology of and opportunities for prevention of type 1 diabetes.
APA, Harvard, Vancouver, ISO, and other styles
42

Bray, George A. "Preventing Diabetes: Lessons Learned from the Diabetes Prevention Program and Its Follow-Up." Obesity and Weight Management 5, no. 6 (December 2009): 273–76. http://dx.doi.org/10.1089/obe.2009.0603.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Newlin Lew, Kelley, Emma McKim Mitchell, and Yolanda Mclean. "Diabetes prevention and management among minority ethnic groups in Nicaragua: Findings from Phase 2 of a community-based participatory research study." Health Education Journal 75, no. 8 (July 28, 2016): 939–49. http://dx.doi.org/10.1177/0017896916638701.

Full text
Abstract:
Objectives: To (1) describe barriers to diabetes prevention and self-management, (2) explore how religious beliefs inform diabetes prevention and self-management and (3) describe community action strategies to address the problem of diabetes locally. Design: Qualitative, descriptive design. Setting: Three Moravian Churches located, respectively, in Bluefields, Pearl Lagoon and Tasbapounie on Nicaragua’s Southern Atlantic Coast. Methods: Using convenience sampling procedures, local church pastors or leaders, health professionals and local lay adults with or at-risk for type 2 diabetes were recruited. Structured by an interview guide, focus groups were conducted. Data were analysed using Krippendorff’s content analysis method. Results: Barriers to diabetes prevention and self-management behaviours included financial constraints, inconsistent availability of diabetes medications and testing supplies, and limited diabetes knowledge. Religious faith was identified as central in coping with the daily demands of preventing or self-managing diabetes. Community action strategies to address diabetes included (1) the formation of interdisciplinary diabetes teams, (2) church-based diabetes care and (3) public health announcements. Conclusion: Findings informed culturally sensitive diabetes prevention and self-management education through the identified community action strategies.
APA, Harvard, Vancouver, ISO, and other styles
44

Müller, G., G. Weser, and P. E. H. Schwarz. "The European perspective of diabetes prevention: The need for individualization of diabetes prevention." Journal of Endocrinological Investigation 36, no. 5 (May 2013): 352–57. http://dx.doi.org/10.1007/bf03347104.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Rahmi, Anggun Hidayatur. "Covid-19 Prevention Model in People with Diabetes Mellitus Based on Health Promotion Model." British Journal of Nursing Studies 3, no. 1 (May 20, 2023): 55–63. http://dx.doi.org/10.32996/bjns.2023.3.1.8.

Full text
Abstract:
Diabetes mellitus is identified as one of the factors of COVID-19. People with diabetes, when infected with COVID-19, will experience worse clinical symptoms. This study aims to develop a model for preventing COVID-19 in people with diabetes mellitus using the Health Promotion Model theory from Nola J Pender. This study used a cross-sectional approach. The population in this study was diabetes mellitus patients at Al Mustofa Lamongan Clinic. The sample size was 110 respondents. The sampling technique used is simple random sampling. The variables in this study are biological factors, previous behavioral factors, psychological factors, sociocultural factors, cognition and affection, family support factors, and prevention of COVID-19 in people with diabetes mellitus. Data analysis used Partial Least Square (PLS). Psychological actors (motivation, personality, anxiety) influenced factors of cognition and affection. Psychological actors influence family support factors. Sociocultural factors (education, norms, and social networks) influence family support. Cognition and affection factors (barriers, benefits, and self-efficacy) influence COVID-19 prevention behaviors. Family support factors (emotional, instrumental, reward, and informational support) influence COVID-19 prevention behavior in people with diabetes mellitus with a statistical T value of > 1.96. Improving the prevention of COVID-19 for people with diabetes mellitus is carried out by increasing one's understanding of the benefits and barriers of preventing COVID-19 and increasing self-efficiency. Family involvement in COVID-19 prevention and its active role in improving COVID-19 prevention. Active family involvement in COVID-19 prevention can increase confidence to behave according to the expectations of important people such as family. Family plays an essential role in prevention efforts.
APA, Harvard, Vancouver, ISO, and other styles
46

Palmer, J. P., and D. K. McCulloch. "Prediction and prevention of IDDM--1991." Diabetes 40, no. 8 (August 1, 1991): 943–47. http://dx.doi.org/10.2337/diabetes.40.8.943.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Azizur Rahman, Mohammad, and Rabeya Akter. "Diabetes Ameliorating Effect of Mushrooms." Biomedical Research and Clinical Reviews 5, no. 1 (October 29, 2021): 01–05. http://dx.doi.org/10.31579/2692-9406/086.

Full text
Abstract:
The growing impact of type 2 diabetes in the majority of the population requires the introduction of better and more secure treatments, but also requires the development of new prevention strategies to reduce the incidence and prevalence of the disease. Significantly, type 2 diabetes is an important preventable disease and can be prevented or delayed by lifestyle intervention. Edible and medicinal macrofungi, mushrooms have been reported having diabetes ameliorating effects. Current study reviews the potentiality of both edible and medicinal mushrooms in preventing and ameliorating the diabetic complications as well as the future aspects of mushrooms against this metabolic disorder.
APA, Harvard, Vancouver, ISO, and other styles
48

Mani, Hamidreza, Kamlesh Khunti, Miles Levy, and Melanie J. Davies. "Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention." Diabetes Management 3, no. 6 (November 2013): 467–80. http://dx.doi.org/10.2217/dmt.13.54.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Kurniawan, Titis, Irfani Nurfuadah, and Dian Adiningsih. "Diabetic Patients’ Family’s Health Beliefs Toward Diabetes Prevention and The Contributing Factors." Media Keperawatan Indonesia 3, no. 3 (October 31, 2020): 175. http://dx.doi.org/10.26714/mki.3.3.2020.175-179.

Full text
Abstract:
Health beliefs among family members of diabetic patients are important factor of the diabetic preventing behaviours. This study aimed to describe family’s beliefs toward diabetes mellitus prevention based on the Health Belief Model and its’ contributing factors. This corelational study involved 72 peoples that purposively sampled from 34 diabetic patients who live in Jatinangor Public Health Center Working area. A questionnaire developed by the research team consisted of 37 items and 6 domains: perceived susceptibility, severity, benefits, barriers, cues to action, and self efficacy was used to collect the data. The collected data were analyzed descriptively and inferentially. The results showed that most of respondents (77.78%) positively believed on diabetes mellitus (DM) susceptibility, severity (59.72%), benefits of DM prevention (84.77%), and cues to action (76.4%). It was also found that most of respondents negatively believed on the prevention barriers (84%) and self-efficacy (77.78%). Female and actively involved in patient care were found as the contributing factors of the respondents’ beliefs related to DM prevention (p<0.05). To conclude, the DM patients’ family members believed that they are vulnerable to have DM and DM preventions are beneficial. Female and being actively involved in patient care potentially increase the family members’ beliefs toward DM prevention. So, it is important for the healthcare professionals to maximize the family members’ involvement in DM patient care program.
APA, Harvard, Vancouver, ISO, and other styles
50

Yeap, Bu B., and Gary A. Wittert. "Testosterone, Diabetes Risk, and Diabetes Prevention in Men." Endocrinology and Metabolism Clinics of North America 51, no. 1 (March 2022): 157–72. http://dx.doi.org/10.1016/j.ecl.2021.11.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Diabetes – Prevention' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography